JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8405 Cytarabine
1 Citation

Summary: cytotoxic agent, blocks DNA synthesis

insoluble in EtOH; ≥28.6 mg/mL
B3261 RO4987655

Summary: MEK inhibitor

insoluble in H2O; insoluble in EtOH; ≥56.6 mg/mL
B1642 WYE-125132 (WYE-132)

Target: mTOR

Summary: ATP-competitive mTOR inhibitor, highly potent

insoluble in EtOH; insoluble in H2O; ≥13 mg/mL
B2075 Ambrisentan

Target: ETA Receptors

Summary: ETA-receptor antagonist

insoluble in H2O; ≥18.92 mg/mL
B1302 Amsacrine

Summary: Topoisomerase 2 inhibitor

≥26.5 mg/mL
B1054 Resiquimod (R-848)
6 Citation

Target: Toll-like receptors (TLRs)

Summary: Toll-like receptor 7/8 (TLR7/8) dual agonist; for autoimmune disease models
A1037 TRH Precursor Peptide

Summary: Thyrotropin Releasing Hormone Precursor Peptide

≥100.6 mg/mL
B8509 INH14

Summary: Inhibitor of IKKα/β-dependent TLR inflammatory responses

≥36 mg/mL
B5575 SC 66

Summary: Akt inhibitor

Soluble in DMSO
B5581 SR 1664

Summary: inhibits Cdk5-mediated PPARγ phosphorylation, antidiabetic agent

Soluble in DMSO